Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$1.39 - $2.27 $51 - $83
37 New
37 $0
Q4 2023

Feb 02, 2024

BUY
$1.52 - $2.04 $1,931 - $2,592
1,271 New
1,271 $2,000
Q2 2021

Aug 12, 2021

SELL
$3.35 - $5.67 $3,065 - $5,188
-915 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$4.75 - $6.87 $15,442 - $22,334
-3,251 Reduced 78.04%
915 $5,000
Q4 2020

Feb 02, 2021

BUY
$5.35 - $7.77 $22,288 - $32,369
4,166 New
4,166 $22,000
Q3 2020

Oct 14, 2020

SELL
$7.22 - $9.11 $1,061 - $1,339
-147 Closed
0 $0
Q2 2020

Jul 13, 2020

BUY
$4.93 - $10.26 $724 - $1,508
147 New
147 $1,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $51.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.